This is a snippet of the transcript, sign up to read more.
The Fuyao story was driven more by the OEMs than the aftermarket. Safelite is all aftermarket, which is a different business. The OEMs are trying to supply their production lines in the US and found it difficult and risky to supply from China. They have parts coming from everywhere, but a car production line operates 24/7, producing car after car. If the glass piece isn't available or right, it can cause the production line to go down, costing anywhere from $10,000 to $100,000 per minute. OEMs are extremely risk-averse. As glass technology became more sophisticated, dealing with quality issues and ensuring they had the necessary parts at the required quality level led them to want at least a segment of their supply base in North America, not China.
This is a snippet of the transcript, sign up to read more.
When producing a part for a General Motors factory, for example, the dimensions must be exact. It's not just about the glass; it's about all the additional components that make it challenging. For instance, a windshield supplied to General Motors or any OEM has alignment pins and a rubber seal. If these aren't precisely placed, it could potentially halt the production line. The effort to ensure quality for an OEM part is significantly greater than for an aftermarket part. Aftermarket parts might not even have alignment pins and are installed by a technician, making it more of a custom job. The precision required isn't the same as in automated production. The quality checks for aftermarket parts, which go from the glass supplier to a warehouse and then to a technician, aren't as rigorous as those for automotive OEM plants. OEM representatives monitor the production line, and any issues require immediate attention. In contrast, the aftermarket side is more relaxed. The quality specifications and requirements aren't as stringent.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.